Literature DB >> 22531902

The role of imaging in the management of non-metastatic cervical cancer.

Orit Kaidar-Person1, Roxolyana Bortnyak-Abdah, Amnon Amit, Alison Berniger, Rahamim Ben-Yosef, Abraham Kuten.   

Abstract

The role of the physician is to choose the best treatment in terms of survival benefits with the lowest toxicity. Surgery is indicated for early disease, but insufficient pretreatment evaluation may result in an unnecessary procedure or the need for adjuvant therapy. Appropriate imaging may aid in these decisions. Involvement of imaging in radiotherapy allows more accurate and localized irradiation. Confirmation of correct patient positioning is an integral part of radiotherapy, and in the era of modern imaging, newer image-guided techniques are used to ensure adequate positioning of the target. It seems that the evolution of radiotherapy in the era of advanced imaging and the field of adaptive radiotherapy in uterine cervical cancer is a result of the availability of these novel modalities. This review discusses the role of imaging in the treatment planning of cervical cancer.

Entities:  

Mesh:

Year:  2012        PMID: 22531902     DOI: 10.1007/s12032-012-0238-4

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  51 in total

1.  PTV margins should not be used to compensate for uncertainties in 3D image guided intracavitary brachytherapy.

Authors:  Kari Tanderup; Richard Pötter; Jacob Christian Lindegaard; Daniel Berger; André Wambersie; Christian Kirisits
Journal:  Radiother Oncol       Date:  2010-09-29       Impact factor: 6.280

2.  Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study.

Authors:  Donald G Mitchell; Bradley Snyder; Fergus Coakley; Caroline Reinhold; Gillian Thomas; Marco Amendola; Lawrence H Schwartz; Paula Woodward; Harpreet Pannu; Hedvig Hricak
Journal:  J Clin Oncol       Date:  2006-12-20       Impact factor: 44.544

3.  Influence of quantity of lymph vascular space invasion on time to recurrence in women with early-stage squamous cancer of the cervix.

Authors:  Mildred R Chernofsky; Juan C Felix; Laila I Muderspach; C Paul Morrow; Wei Ye; Susan G Groshen; Lynda D Roman
Journal:  Gynecol Oncol       Date:  2005-09-22       Impact factor: 5.482

4.  Adaptive brachytherapy treatment planning for cervical cancer using FDG-PET.

Authors:  Lilie L Lin; Sasa Mutic; Daniel A Low; Richard LaForest; Milos Vicic; Imran Zoberi; Tom R Miller; Perry W Grigsby
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-01-01       Impact factor: 7.038

5.  Detecting para-aortic lymph nodal metastasis by positron emission tomography of 18F-fluorodeoxyglucose in advanced cervical cancer with negative magnetic resonance imaging findings.

Authors:  Lian-Shung Yeh; Yao-Ching Hung; Yeh-You Shen; Chia-Hung Kao; Cheng-Chieh Lin; Cheng-Chun Lee
Journal:  Oncol Rep       Date:  2002 Nov-Dec       Impact factor: 3.906

6.  Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).

Authors:  Takafumi Toita; Shingo Kato; Yuzuru Niibe; Tatsuya Ohno; Tomoko Kazumoto; Takeshi Kodaira; Masaaki Kataoka; Naoto Shikama; Masahiro Kenjo; Sunao Tokumaru; Chikako Yamauchi; Osamu Suzuki; Hideyuki Sakurai; Hodaka Numasaki; Teruki Teshima; Masahiko Oguchi; Yoshikazu Kagami; Takashi Nakano; Masahiro Hiraoka; Norio Mitsuhashi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-04       Impact factor: 7.038

7.  Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix.

Authors:  W A Peters; P Y Liu; R J Barrett; R J Stock; B J Monk; J S Berek; L Souhami; P Grigsby; W Gordon; D S Alberts
Journal:  J Clin Oncol       Date:  2000-04       Impact factor: 44.544

Review 8.  New trends in the evaluation and treatment of cervix cancer: the role of FDG-PET.

Authors:  Nicolas Magné; Cyrus Chargari; Lisa Vicenzi; Norman Gillion; Taha Messai; Jacques Magné; Gérald Bonardel; Christine Haie-Meder
Journal:  Cancer Treat Rev       Date:  2008-10-11       Impact factor: 12.111

9.  Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer.

Authors:  Michael Frumovitz; Charlotte C Sun; Kathleen M Schmeler; Michael T Deavers; Ricardo Dos Reis; Charles F Levenback; Pedro T Ramirez
Journal:  Obstet Gynecol       Date:  2009-07       Impact factor: 7.661

10.  Detection of pelvic lymph node micrometastasis in stage IA2-IB2 cervical cancer by immunohistochemical analysis.

Authors:  Margrit M Juretzka; Kristin C Jensen; Teri A Longacre; Nelson N Teng; Amreen Husain
Journal:  Gynecol Oncol       Date:  2004-04       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.